BillionToOne Q3 Revenues More Than Double Year Over Year

Original from: genomeweb

Molecular diagnostics firm BillionToOne reported after the close of the market on Tuesday that its Q3 2025 revenues more than doubled year over year.

For the three months ended Sept. 30, BillionToOne reported revenues of $83.5 million, up from $38.4 million in Q3 2024.

Founded in 2016, the Menlo Park, California-based company went public on Nov. 6 in a $237 million initial public offering.

Revenue for BillionToOne's prenatal testing business was $74.1 million in Q3, up more than twofold from $36.6 million in the year-ago period. Oncology testing revenues were $8.7 million, up roughly eightfold from $1.1 million in Q3 2024. Revenue from other services was $800,000, up 14 percent from $700,000 in Q3 2024.

The firm accessioned 162,900 tests in Q3, up 51 percent from 107,900 in Q3 2024. It delivered 165,000 tests in the recently completed quarter, up 52 percent from 108,500 in the year-ago period.

"This quarter reinforced our view about how a unique, innovative technology combined with disciplined execution can drive a differentiated financial profile in molecular diagnostics," BillionToOne Cofounder and CEO Oguzhan Atay said in a statement accompanying the release of the Q3 financial results.

BillionToOne's net income for the quarter was $1.5 million, or $.10 per share, compared to a net loss of $14.9 million, or $1.47 per share, in Q3 2024. The company used 15,571,949 shares to calculate the Q3 2025 EPS figure and 10,107,487 to calculate the Q3 2024 loss per share figure.

The firm's R&D expenses for the recently completed quarter were $13.0 million, up 35 percent from $9.6 million a year ago. Its SG&A expenses were $35.8 million, up 54 percent from $23.3 million.

BillionToOne ended the quarter with $195.2 million in cash and cash equivalents.

The company said it expects Q4 2025 revenue of between $84 million and $90 million, which would represent growth of between 86 percent and 100 percent compared to Q4 2024. It anticipates full-year 2025 revenues of between $293 million and $299 million, which would represent growth of between 93 percent and 96 percent compared to full-year 2024.

Source: BillionToOne Q3 Revenues More Than Double Year Over Year